Gastric

1. IHC

1.1. CK7

1.2. Differentiation

1.3. Overexpression

1.3.1. HER2

1.3.2. MET

2. Mutations

3. Gene fusion

3.1. ROS1

4. CNV CGH

4.1. Amplifications

4.1.1. MET

4.1.1.1. 26404902

4.2. Deletions

5. Exome

6. Targeted therapy

6.1. ERBB2

6.1.1. trastuzumab

6.2. VEGFR2

6.2.1. ramucirumab

6.2.2. apatinib

6.3. MET

6.3.1. crizotinib